General program support services for congressionally directed medical research programs (cdmrp)
Ended Awarded Last action
- Contract number
- W81XWH22F0237
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,036,681
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Contract value 50% obligated
-
- $1,046,695.40 Current, with exercised options
- $2,062,348.83 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $11,082 | |
| Original award | $1,025,599 |
About this award
Leidos, Inc., operating through its Saic division, was awarded a $2.1 million delivery order against an unspecified governmentwide acquisition contract by the Defense Health Agency to provide general program support services for the Congressionally Directed Medical Research Programs. Under the one-year cost-plus-fixed-fee contract, Leidos will support the CDMRP, which funds medical research projects in the areas of breast cancer, prostate cancer, kidney cancer, and other diseases, at its Fort Detrick, Maryland location. As the prime contractor, Leidos will likely utilize its extensive health research and program management capabilities without the use of major subcontractors. The contract furthers the Defense Health Agency's mission to support Department of Defense medical research initiatives.
Quick answers
Who was awarded contract W81XWH22F0237?
W81XWH22F0237 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on August 30, 2022.
How much is contract W81XWH22F0237 worth?
The government has obligated $1,036,681 on W81XWH22F0237. Its current value, with exercised options, is $1,046,695. Its potential value, with all options, is $2,062,349.
Which agency awarded contract W81XWH22F0237?
Medical Command (Department of the Army) awarded W81XWH22F0237, with funding from Defense Health Agency (Department of Defense).
Is contract W81XWH22F0237 an order under another contract?
Yes. W81XWH22F0237 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH22F0237 competed?
The extent of competition for W81XWH22F0237 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award